[HTML][HTML] Osteoarthritis year in review 2019: epidemiology and therapy

M Kloppenburg, F Berenbaum - Osteoarthritis and cartilage, 2020 - Elsevier
Over the past year many studies and clinical trials have been published in the osteoarthritis
(OA) field. This review is based on systematic literature review covering the period May 1 st …

Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR …

A Ortolan, C Webers, A Sepriano, L Falzon… - Annals of the rheumatic …, 2023 - Elsevier
Objective To update the evidence of non-biological treatments for axial spondyloarthritis
(axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international Society …

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis

D Wendling, S Hecquet, O Fogel, JG Letarouilly… - Joint Bone Spine, 2022 - Elsevier
Abstract Objective: Update the French Society for Rheumatology (SFR) recommendations
on the everyday management of patients with spondyloarthritis, including psoriatic arthritis …

Bioactive factors for cartilage repair and regeneration: improving delivery, retention, and activity

JM Patel, KS Saleh, JA Burdick, RL Mauck - Acta Biomaterialia, 2019 - Elsevier
Articular cartilage is a remarkable tissue whose sophisticated composition and architecture
allow it to withstand complex stresses within the joint. Once injured, cartilage lacks the …

Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological …

P Ferdinandy, I Andreadou, GF Baxter, HE Bøtker… - Pharmacological …, 2023 - Elsevier
Preconditioning, postconditioning, and remote conditioning of the myocardium enhance the
ability of the heart to withstand a prolonged ischemia/reperfusion insult and the potential to …

Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis

JW Liew, S Ramiro, LS Gensler - Best practice & research Clinical …, 2018 - Elsevier
The cardiovascular burden in inflammatory rheumatic diseases is well recognized. Recently,
this burden has been highlighted in ankylosing spondylitis (also known as radiographic …

Gelatin/O-carboxymethyl chitosan injectable self-healing hydrogels for ibuprofen and naproxen dual release

M Mohseni, P Shokrollahi, J Barzin - International Journal of Biological …, 2024 - Elsevier
Recently, a significantly greater clinical benefit has been reported with a combination of
glucosamine sulfate and nonsteroidal anti-inflammatory drugs (NSAIDs) compared to either …

Nonsteroidal antiinflammatory drugs and susceptibility to COVID‐19

JS Chandan, DT Zemedikun… - Arthritis & …, 2021 - Wiley Online Library
Objective To identify whether active use of nonsteroidal antiinflammatory drugs (NSAIDs)
increases susceptibility to develo** suspected or confirmed coronavirus disease 2019 …

Nonsteroidal anti-inflammatory drugs and cardiovascular risk–a matter of indication

J Braun, X Baraliakos, T Westhoff - Seminars in arthritis and rheumatism, 2020 - Elsevier
The term non-steroidal anti-inflammatory drugs (NSAIDs) covers a heterogeneous group of
compounds that possess analgesic, antipyretic and anti-inflammatory properties. NSAIDs …

[HTML][HTML] A review of current approaches to pain management in knee osteoarthritis with a focus on Italian clinical landscape

S Giaretta, A Magni, A Migliore, S Natoli… - Journal of Clinical …, 2024 - mdpi.com
The global cases of knee osteoarthritis (KOA) are projected to increase by 74.9% by 2050.
Currently, over half of patients remain dissatisfied with their pain relief. This review …